ReviewNanomaterials (Basel, Switzerland)2026
Advances and Prospects of Chiral Plasmonic Nanomaterials in Emerging Applications.
Review in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiral plasmonic nanostructures have emerged as a distinctive class of optical materials that combine nanoscale structural asymmetry with strong light-matter interactions, enabling pronounced and tunable chiroptical responses. Advances in structural engineering and plasmonic coupling have enabled diverse architectures with potential applications in enantioselective sensing, asymmetric catalysis, bioimaging, and therapeutic technologies. However, their broader development remains constrained by several key challenges, including precise control over nanoscale chirality, batch-to-batch structural reproducibility, incomplete understanding of structure-chiroptical property relationships, scalable fabrication, and stability under practical and biological conditions. This review systematically examines the major structural architectures of chiral plasmonic nanomaterials and the mechanisms responsible for chirality generation, including ligand-induced, intrinsic geometric, and assembly induced chirality. Particular emphasis is placed on correlating structural design, plasmonic coupling, and chiroptical properties with functional performance. Recent advances in enantioselective recognition and sensing, catalytic transformations, and biomedical applications are critically discussed, together with their current limitations. Finally, emerging design strategies and future opportunities for improving structural precision, reproducibility, scalability, and practical translation are highlighted, providing a framework for the rational development of next-generation chiral plasmonic nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.